drugset / Trial / NCT07567781
A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.
NaSingle-groupOpen-labelBasic science
Summary
The objective of this study is to assess the effect of repeated doses of ABBV-722 on the single dose pharmacokinetics (PK) of Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin
Timeline
- Start
- 2026-04-30
- Primary completion
- 2026-07
- Completion
- 2026-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-722 | Unknown | — | Oral |
| Subject | Digoxin | Other / unclassified | — | Oral |
| Subject | Metformin | Small molecule | — | Oral |
| Subject | Midazolam | Small molecule | — | Oral |
| Subject | Pitavastatin | Small molecule | — | Oral |
| Subject | Sitagliptin | Small molecule | — | Oral |
Indications
No indication recorded.